| Literature DB >> 32975651 |
Igor Santana de Melo1, Amanda Larissa Dias Pacheco1, Yngrid Mickaelli Oliveira Dos Santos1, Laura Mello Figueiredo1, Dannyele Cynthia Santos Pimentel Nicacio1, Leia Cardoso-Sousa2, Marcelo Duzzioni1, Daniel Leite Góes Gitaí1, Cristiane Queixa Tilelli3, Robinson Sabino-Silva4, Olagide Wagner de Castro5.
Abstract
Status epilepticus (SE) can lead to serious neuronal damage and act as an initial trigger for epileptogenic processes that may lead to temporal lobe epilepsy (TLE). Besides promoting neurodegeneration, neuroinflammation, and abnormal neurogenesis, SE can generate an extensive hypometabolism in several brain areas and, consequently, reduce intracellular energy supply, such as adenosine triphosphate (ATP) molecules. Although some antiepileptic drugs show efficiency to terminate or reduce epileptic seizures, approximately 30% of TLE patients are refractory to regular antiepileptic drugs (AEDs). Modulation of glucose availability may provide a novel and robust alternative for treating seizures and neuronal damage that occurs during epileptogenesis; however, more detailed information remains unknown, especially under hypo- and hyperglycemic conditions. Here, we review several pathways of glucose metabolism activated during and after SE, as well as the effects of hypo- and hyperglycemia in the generation of self-sustained limbic seizures. Furthermore, this study suggests the control of glucose availability as a potential therapeutic tool for SE.Entities:
Keywords: Epilepsy; Glucose; Hyperglycemia; Hypoglycemia; Hypometabolism; Status epilepticus
Year: 2020 PMID: 32975651 DOI: 10.1007/s12035-020-02133-8
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.590